UASt regulates expression of a mutant Hsap\ALK cDNA in which the tyrosine at position 1278 is changed to alanine, a mutation that is observed in neuroblastoma patients and which results in gain-of-function activity.
decreased body size | P-stage, with Scer\GAL4elav-C155
visible | adult stage, with Scer\GAL4GMR.PU
eye, with Scer\GAL4GMR.PU
pupa, with Scer\GAL4elav-C155
The expression of Hsap\ALKY1278S.UAS under the control of Scer\GAL4GMR.PU induces a severe rough eye phenotype.